Two projects already approved and five more in development – with these impressive numbers and a potential market of 183 million patients, the hot stock of the week presents itself as a company with enormous potential.
The need for effective therapies to treat diseases of the central nervous system is enormous and constantly increasing. Diseases such as Alzheimer’s, Parkinson’s, epilepsy and depression are becoming increasingly common in our society and represent a significant challenge for medical research. With two pending regulatory submissions and multiple Phase 3 trial results, the biotech company is facing a crucial year. If successful, this hot stock could move into a whole new league.
You can read about which company it is and how investors can get the most out of the biotech stock in the current issue of DER AKTIONÄR (S. 10).
Other topics in the magazine:
Payday!
New year, new stocks. Namely ones that allow you to cash in every month of the year. DER AKTIONÄR presents you in the new issue Dividend shares from companies that have been reliably paying out profit shares for years and even increase them regularly. (p. 12)
Shake it!
Are protein shakes only for those who lift heavy weights? No longer. The weight loss trend is bringing strong growth to the industry. The top tip of the week is bursting with power. (p. 28)
Too much of a bad thing
The gold industry was not exactly one of investors’ favorites in 2023. Some stocks have lost significantly despite gold hitting a record high. But the problems should be a thing of the past and some stocks offer an excellent comeback chance in 2024. (p. 32)
Watchlist of professionals
Fund managers and asset managers are always very close to the market. DER AKTIONÄR asked which small and mid caps the professional investors have put on their watchlist for 2024. (p. 40)
Bespoke start to the year
Bitcoin gained almost 160 percent in 2023 and continued its dynamic upward movement at the start of the new year. If the bulls have their way, that was just the beginning and 2024 will be the “Year of Bitcoin”. (P.56)
THE SHAREHOLDER subscription offer
Photo: Börsenmedien AG
Cash in 12 times – dividend stocks for your high-yield 2024
2024-01-04 16:53:28
#Hot #stock #focus #crucial #year #biotech #companies
